TY - JOUR
T1 - Evaluation of an individual feedback report on patient-reported outcomes in the Prospective Dutch ColoRectal Cancer cohort
AU - Vissers, Pauline A J
AU - Vink, Geraldine R
AU - Koelink, Maaike R
AU - Koopman, Miriam
AU - Arts, Lindy P J
AU - Oerlemans, Simone
AU - May, Anne M
AU - van de Poll-Franse, Lonneke V
AU - van Erning, Felice N
N1 - Funding Information:
The development of the feedback application, initially developed for the LIVE trial, was financially supported by the Jonker-Driessen Foundation. The current study was supported by a grant from the Dutch Digestive Foundation (project number 17–04). The funding agencies had no role in the design of the study, data collection, analysis and interpretation of data, writing of the report or in the decision to submit the paper for publication.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2022/9
Y1 - 2022/9
N2 - PURPOSE: Returning patient-reported outcomes to patients might aid patients in detecting symptoms and might facilitate early intervention. This descriptive study evaluates the use of an individual feedback report on patient-reported outcomes for colorectal cancer patients and aims to assess differences in patient, tumor, and treatment characteristics and cohort retention between patients who opt and do not opt for the feedback report.METHODS: Patients with colorectal cancer participating in the nationwide Prospective Dutch ColoRectal Cancer Cohort, who filled in questionnaires digitally between June 2018 and January 2019, were included. Participants were given the option to receive a feedback report at baseline, 3, 6, and 12 months. The usefulness, content, and layout of the feedback report were evaluated. Differences in patient, tumor, and treatment characteristics, patient-reported outcomes, and cohort retention at subsequent questionnaires between participants who did and did not opt for feedback were assessed.RESULTS: A total of 484 participants were included of whom 293 (61%) opted for feedback. The feedback report was considered useful by 92%. No differences in patient, tumor, and treatment characteristics, and patient-reported outcomes were found between participants who did and did not opt for feedback. The response rate was higher among patients who opted for feedback compared to patients who did not opt for feedback at T3 (84 vs 74%), but not at T6 and T12.CONCLUSION: The feedback report was used by 6 out of 10 patients. The feedback report was considered valuable and associated with a higher subsequent response rate.
AB - PURPOSE: Returning patient-reported outcomes to patients might aid patients in detecting symptoms and might facilitate early intervention. This descriptive study evaluates the use of an individual feedback report on patient-reported outcomes for colorectal cancer patients and aims to assess differences in patient, tumor, and treatment characteristics and cohort retention between patients who opt and do not opt for the feedback report.METHODS: Patients with colorectal cancer participating in the nationwide Prospective Dutch ColoRectal Cancer Cohort, who filled in questionnaires digitally between June 2018 and January 2019, were included. Participants were given the option to receive a feedback report at baseline, 3, 6, and 12 months. The usefulness, content, and layout of the feedback report were evaluated. Differences in patient, tumor, and treatment characteristics, patient-reported outcomes, and cohort retention at subsequent questionnaires between participants who did and did not opt for feedback were assessed.RESULTS: A total of 484 participants were included of whom 293 (61%) opted for feedback. The feedback report was considered useful by 92%. No differences in patient, tumor, and treatment characteristics, and patient-reported outcomes were found between participants who did and did not opt for feedback. The response rate was higher among patients who opted for feedback compared to patients who did not opt for feedback at T3 (84 vs 74%), but not at T6 and T12.CONCLUSION: The feedback report was used by 6 out of 10 patients. The feedback report was considered valuable and associated with a higher subsequent response rate.
KW - Cohort retention
KW - Colorectal cancer
KW - Individual feedback report
KW - Patient-reported outcomes
KW - Prospective Dutch ColoRectal Cancer Cohort
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=85130565592&partnerID=8YFLogxK
U2 - 10.1007/s00520-022-07165-5
DO - 10.1007/s00520-022-07165-5
M3 - Article
C2 - 35606477
SN - 0941-4355
VL - 30
SP - 7303
EP - 7312
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 9
ER -